Advertisement

AGE

, Volume 28, Issue 1, pp 77–84 | Cite as

Design for a study to determine optimal dosage of ascorbic acid and alpha-tocopherol in humans

  • Leta R. Moser
  • Alfred B. OrdmanEmail author
Original Paper

Abstract

Some clinical trials of vitamins C and E have neglected important design features. Our objective was to demonstrate a detailed design that includes essential elements for an effective study of these vitamins in vivo. While taking 400 IU (international units) of vitamin E, subjects took different dosages of vitamin C during three distinct periods. Dosages were 200 mg in food, 500 mg as supplements twice a day (500 × 2), and 1,000 mg as supplements twice a day (1000 × 2). Ten participants spent 3 weeks at each dosage before plasma was drawn on two consecutive days. Final samples were taken after a week with no supplementation. Selected by investigators at four institutions, endpoints were protein carbonyls, TBARs (thiobarbituric reactive substances), and Heinz body formation in RBCs (red blood cells). TBARs and protein carbonyls did not change significantly with dosage. However, Heinz body formation increased at either higher or lower intakes of vitamin C. Even with daily vitamin E, Heinz bodies were significantly fewer at 500 × 2. Results indicate that even with 400 IU vitamin E daily, it is possible to distinguish the effect of different levels of vitamin C with Heinz bodies. This effect may be due to pro-oxidant action of vitamin C or to prolonged survival of RBCs.

Key words

antioxidants ascorbic acid free radicals Heinz bodies protein carbonyls TBARs tocopherol vitamin C vitamin E 

Abbreviations

AA

ascorbic acid/vitamin C

AGE

American Aging Association

ANOVA

Analysis of variance

AT

dl-alpha-tocopheryl-acetate/vitamin E

DCIP

dichlorophenol-indophenol

DNP

dinitrophenol

ELISA

enzyme-linked immunosorbent assay

IU

international units

NIH

National Institutes of Health

RBC

red blood cells

SUP

supplement

TBARS

thiobarbituric acid reactive substances

UL

Upper limit

500 × 2

500 mg AA twice a day

1000 × 2

1000 mg AA twice a day

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. American Aging Assocation (AGE) Conference (2003, June 6-9) Nutritional Modulation of Aging and Age-Related DiseasesGoogle Scholar
  2. Annual Meeting of the Linus Pauling Institute (May 16–20, 2003)Google Scholar
  3. Beckman KB, Ames BN (1998) The free radical theory of aging matures. Physiol Rev 78:547–581PubMedGoogle Scholar
  4. Beutler E, Lichtman MA, Coller BS et al. (1995) Williams hematology, 5th edn. McGraw-Hill, New York, pp L26Google Scholar
  5. Brockes C, Buchli C, Locher R et al. (2003) Vitamin E prevents extensive lipid peroxidation in patients with hypertension. Br J Biomed Sci 60:5–8PubMedGoogle Scholar
  6. Brown KM, Morrice PC, Duthie GG (1997) Erythrocyte vitamin E and plasma ascorbate concentrations in relation to erythrocyte peroxidation in smokers and nonsmokers: dose response to vitamin E supplementation. Am J Clin Nutr 65:496–502PubMedGoogle Scholar
  7. Burton GW, Darosewska M (1996) Deuterated vitamin E: measurement in tissues and body fluids. In: Punchard NA, Kelly FJ (eds) Free radicals: a practical approach. Oxford University Press, Oxford, pp 257–270Google Scholar
  8. Burton GW, Ingold TU, Cheeseman KH, Slater TF (1990) Application of deuterated alpha-tocopherols to the biokinetics and bioavailablity of vitamin E. Free Radic Res Commun 11:99–107PubMedCrossRefGoogle Scholar
  9. Bruunsgaard H, Poulsen HE, Pedersen BK et al (2003) Long-term combined supplementations with alpha-tocopherol and vitamin C have no detectable anti-inflammatory effects in healthy men. J Nutr 133:1170–1173PubMedGoogle Scholar
  10. Carcamo JM, Pedraza A, Borquez-Ojeda O et al (2004) Vitamin C is a kinase inhibitor: dehydroascorbic acid inhibits IkappaBalpha kinase beta. Mol Cell Biol 24:6645–6652CrossRefPubMedGoogle Scholar
  11. Carty JL, Bevan R, Waller H et al (2000) The effects of vitamin C supplementation on protein oxidation in healthy volunteers. Biochem Biophys Res Commun 273:729–735CrossRefPubMedGoogle Scholar
  12. Cone A, Danner T, Ordman AB (1996) Urinary excretion of calcium in students and mature women taking supplements. AGE 19:164Google Scholar
  13. Curhan GC, Willett WC, Rilmm EB, Stampfer MJ (1996) A prospective study of the intake of vitamins C and B6, and the risk of kidney stones in men. J Urol 155:1847–1851CrossRefPubMedGoogle Scholar
  14. de Zwart, LL, Meerman JH, Commandeur JN, Vermeulen NP (1999) Biomarkers of free radical damage: applications in experimental animals and in humans. Free Radic Biol Med 26:202–226CrossRefPubMedGoogle Scholar
  15. Fang JC, Kinlay S, Beltrame J et al (2002) Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial. Lancet 359:1108–1113CrossRefPubMedGoogle Scholar
  16. Haan MN (2003) Can vitamin supplements prevent cognitive decline and dementia in old age. Am J Clin Nutr 77:762–763PubMedGoogle Scholar
  17. Hathcock JN, Azzi A, Blumberg J et al (2005) Vitamins E and C are safe across a broad range of intakes. Am J Clin Nutr 81:736–745PubMedGoogle Scholar
  18. Heitzer TH, Just H, Munzel T (1996) Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation 94:6–98PubMedGoogle Scholar
  19. Huang H, Appel LJ, Croft KD et al (2002) Effects of vitamin C and vitamin E on in vivo lipid peroxidation: results of a randomized controlled trial. Am J Clin Nutr 76:549–555PubMedGoogle Scholar
  20. Jacob RA, Alello GM, Stephensen CB, Blumberg JB, Milbury PE, Wallock LM, Ames BN (2003) Moderate antioxidant supplementation has no effect on biomarkers of oxidant damage in healthy men with low fruit and vegetable intakes. J Nutr 133:740–743PubMedGoogle Scholar
  21. Jakubowska-Solarska B, Solski J (2000) Sialic acids of young and old red blood cells in healthy subjects. Med Sci Monit 6:871–874PubMedGoogle Scholar
  22. Johnston CS, Cox SK (2001) Plasma-saturating intakes of vitamin C confer maximal antioxidant protection to plasma. Am J Clin Nutr 20:623–627Google Scholar
  23. King G, Beins M, Larkin J, Summers B, Ordman AB (1994) Rate of excretion of vitamin C in human urine. AGE 17:87–92CrossRefGoogle Scholar
  24. Levine M, Conry-Cantilena C, Wang, Y et al (1996) Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. PNAS USA 93:3704–3709CrossRefPubMedGoogle Scholar
  25. Lewis SM, Bain BJ, Bates I, Dacie L (1995) Practical haematology, 8th edn. Churchill Livingstone, LondonGoogle Scholar
  26. Losonczy KG, Harris TB, Havlik RJ (1996) Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: the Established Populations for Epidemiologic Studies of the Elderly. Am J Clin Nutr 64:190–196PubMedGoogle Scholar
  27. Mayne ST (2003) Antioxidant nutrients and chronic disease: use of biomarkers and oxidative stress status in epidemiologic research. J Nutr 133:933S–940SPubMedGoogle Scholar
  28. Meydani M (1999) Consensus conference: do vitamins E and C produce beneficial effects on aging and age-related disease? AGE 22:116Google Scholar
  29. Meydani SN, Meydani M, Blumberg JB et al (1997) Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial. JAMA 277:1380–1386CrossRefPubMedGoogle Scholar
  30. NIH (2003, June 26-27) Conference Free Radicals: The Pros and Cons of AntioxidantsGoogle Scholar
  31. Ordman AB (1999) Background for a consensus on the value of consuming vitamin C and E supplements. AGE 22:127Google Scholar
  32. Packer L, Traber MG, Kraiemer K, Frei B (eds) (2002) The antioxidant vitamins C and E. AOCS Press, ChampaignGoogle Scholar
  33. Poulsen HE, Weimann A, Salonen JT et al (1998) Does vitamin C have a pro-oxidant effect? Nature 395:231–232CrossRefPubMedGoogle Scholar
  34. Steinberg FM, Chait A (1998) Antioxidant vitamin supplementation and lipid peroxidation in smokers. Am J Clin Nutr 68:319–327PubMedGoogle Scholar
  35. Traber MG (1999) Vitamin E. In: Shils ME, Olson JA, Shike M, Ross AC (eds) Modern nutrition in health and disease. Williams & Wilkins, Baltimore, pp 347–362Google Scholar
  36. Winklhofer-Roob BM, Ziouzenkova O, Puhl H et al (1995) Impaired resistance to oxidation of low density lipoprotein in cystic fibrosis: improvement during vitamin E supplementation. Free Radic Biol Med 19:725–733CrossRefPubMedGoogle Scholar
  37. Winterbourn CC, Buss IH (2002) Protein carbonyl measurement by enzyme-linked immunosorbent assay. Methods Enzymol 300:106–111CrossRefGoogle Scholar
  38. Yagi K (1998) Simple assay for the level of total lipid peroxides in serum or plasma. In: Armstrong D (ed) Free radical and antioxidant protocols. Barnes & Noble, New YorkGoogle Scholar

Copyright information

© Springer Science + Business Media, Inc. 2006

Authors and Affiliations

  1. 1.Biochemistry ProgramBeloit CollegeBeloitUSA
  2. 2.Department of Cancer BiologyVanderbilt UniversityNashvilleUSA
  3. 3.Department of BiochemistryRush UniversityChicagoUSA

Personalised recommendations